- Home
- SOTK vs HOWL Comparison
SOTK vs HOWL Comparison
Compare SOTK & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- HOWL
- Stock Information
- Founded
- SOTK 1975
- HOWL 2017
- Country
- SOTK United States
- HOWL United States
- Employees
- SOTK 89
- HOWL N/A
- Industry
- SOTK Industrial Machinery/Components
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- HOWL Health Care
- Exchange
- SOTK Nasdaq
- HOWL Nasdaq
- Market Cap
- SOTK 52.1M
- HOWL 47.1M
- IPO Year
- SOTK 1987
- HOWL 2021
- Fundamental
- Price
- SOTK $3.31
- HOWL $1.16
- Analyst Decision
- SOTK Hold
- HOWL Strong Buy
- Analyst Count
- SOTK 1
- HOWL 3
- Target Price
- SOTK N/A
- HOWL $8.33
- AVG Volume (30 Days)
- SOTK 7.9K
- HOWL 354.1K
- Earning Date
- SOTK 07-10-2025
- HOWL 08-15-2025
- Dividend Yield
- SOTK N/A
- HOWL N/A
- EPS Growth
- SOTK N/A
- HOWL N/A
- EPS
- SOTK 0.09
- HOWL N/A
- Revenue
- SOTK $20,606,116.00
- HOWL $1,143,000.00
- Revenue This Year
- SOTK N/A
- HOWL N/A
- Revenue Next Year
- SOTK $7.13
- HOWL N/A
- P/E Ratio
- SOTK $36.78
- HOWL N/A
- Revenue Growth
- SOTK N/A
- HOWL N/A
- 52 Week Low
- SOTK $3.25
- HOWL $0.60
- 52 Week High
- SOTK $6.05
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- SOTK 33.85
- HOWL 40.62
- Support Level
- SOTK $3.25
- HOWL $1.25
- Resistance Level
- SOTK $3.72
- HOWL $1.43
- Average True Range (ATR)
- SOTK 0.09
- HOWL 0.10
- MACD
- SOTK -0.02
- HOWL -0.02
- Stochastic Oscillator
- SOTK 12.77
- HOWL 2.86
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.